Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1990 Aug;66(4):238–243. doi: 10.1136/sti.66.4.238

The natural history of human immunodeficiency virus infection: a five year study in a London cohort of homosexual men.

G E Kelly 1, B S Stanley 1, I V Weller 1
PMCID: PMC1194520  PMID: 2133371

Abstract

Progression rates from asymptomatic to symptomatic Human Immunodeficiency Virus (HIV) infection according to the CDC classification were prospectively studied in a cohort of 172 seropositive homosexual and bisexual men. The median follow-up time was 4 years. The progression from data of entry to the study to any group IV disease was 56% (SE 7%) at 5 years. However, the progression from an estimated date of seroconversion to any group IV disease was 36% (SE 4%) at 5 years. This was more than double the progression rate to AIDS-14% (SE 3%) at 5 years calculated in the same way. There were no differences in progression to AIDS from group IV A (systemic symptoms such as unexplained fever, weight loss or persistent diarrhoea) and group IV C-2 (oral candida or oral hairy leukoplakia). Progression rates to AIDS were significantly lower (p = 0.02) in patients who were under 25 years of age at entry than in those over 25. A review of progression rates to AIDS among homosexual cohorts shows that they tend to be higher than in cohorts of haemophiliac patients, in the early stage of infection. However, when Pneumocystis carinii pneumonia is the outcome measure, progression rates in all studies are remarkably similar.

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carne C. A., Weller I. V., Johnson A. M., Loveday C., Pearce F., Hawkins A., Smith A., Williams P., Tedder R. S., Adler M. W. Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet. 1987 Mar 21;1(8534):656–658. doi: 10.1016/s0140-6736(87)90415-6. [DOI] [PubMed] [Google Scholar]
  2. Eyster M. E., Gail M. H., Ballard J. O., Al-Mondhiry H., Goedert J. J. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987 Jul;107(1):1–6. doi: 10.7326/0003-4819-107-1-1. [DOI] [PubMed] [Google Scholar]
  3. Gelmon K., Weller I. V. Randomised placebo controlled trials in HIV infection: to be or not to be? Genitourin Med. 1989 Jun;65(3):143–145. doi: 10.1136/sti.65.3.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Giesecke J., Scalia-Tomba G., Berglund O., Berntorp E., Schulman S., Stigendal L. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ. 1988 Jul 9;297(6641):99–102. doi: 10.1136/bmj.297.6641.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goedert J. J., Biggar R. J., Weiss S. H., Eyster M. E., Melbye M., Wilson S., Ginzburg H. M., Grossman R. J., DiGioia R. A., Sanchez W. C. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science. 1986 Feb 28;231(4741):992–995. doi: 10.1126/science.3003917. [DOI] [PubMed] [Google Scholar]
  6. Greenspan D., Greenspan J. S., Hearst N. G., Pan L. Z., Conant M. A., Abrams D. I., Hollander H., Levy J. A. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis. 1987 Mar;155(3):475–481. doi: 10.1093/infdis/155.3.475. [DOI] [PubMed] [Google Scholar]
  7. Jason J., Lui K. J., Ragni M. V., Hessol N. A., Darrow W. W. Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA. 1989 Feb 3;261(5):725–727. [PubMed] [Google Scholar]
  8. Kaplan J. E., Spira T. J., Fishbein D. B., Bozeman L. H., Pinsky P. F., Schonberger L. B. A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy. JAMA. 1988 Nov 11;260(18):2694–2697. [PubMed] [Google Scholar]
  9. Klein R. S., Harris C. A., Small C. B., Moll B., Lesser M., Friedland G. H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 9;311(6):354–358. doi: 10.1056/NEJM198408093110602. [DOI] [PubMed] [Google Scholar]
  10. Lifson A. R., Rutherford G. W., Jaffe H. W. The natural history of human immunodeficiency virus infection. J Infect Dis. 1988 Dec;158(6):1360–1367. doi: 10.1093/infdis/158.6.1360. [DOI] [PubMed] [Google Scholar]
  11. Loveday C., Pomeroy L., Weller I. V., Quirk J., Hawkins A., Williams H., Smith A., Williams P., Tedder R. S., Adler M. W. Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7. BMJ. 1989 Feb 18;298(6671):419–422. doi: 10.1136/bmj.298.6671.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marasca G., McEvoy M. Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. Br Med J (Clin Res Ed) 1986 Jun 28;292(6537):1727–1729. doi: 10.1136/bmj.292.6537.1727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moss A. R., Bacchetti P. Natural history of HIV infection. AIDS. 1989 Feb;3(2):55–61. doi: 10.1097/00002030-198902000-00001. [DOI] [PubMed] [Google Scholar]
  14. Polk B. F., Fox R., Brookmeyer R., Kanchanaraksa S., Kaslow R., Visscher B., Rinaldo C., Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med. 1987 Jan 8;316(2):61–66. doi: 10.1056/NEJM198701083160201. [DOI] [PubMed] [Google Scholar]
  15. Rezza G., Lazzarin A., Angarano G., Sinicco A., Pristerà R., Ortona L., Barbanera M., Gafà S., Tirelli U., Salassa B. The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS. 1989 Feb;3(2):87–90. doi: 10.1097/00002030-198902000-00006. [DOI] [PubMed] [Google Scholar]
  16. Rothenberg R., Woelfel M., Stoneburner R., Milberg J., Parker R., Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med. 1987 Nov 19;317(21):1297–1302. doi: 10.1056/NEJM198711193172101. [DOI] [PubMed] [Google Scholar]
  17. Wyld R., Nimmo W. S. Do patients fasting before and after operation receive their prescribed drug treatment? Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):744–744. doi: 10.1136/bmj.296.6624.744. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES